Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector

H. Soifer, C. Higo, Jr H. Kazazian, J. V. Moran, K. Mitani, Noriyuki Kasahara

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Helper-dependent adenoviruses show great promise as gene delivery vectors. However, because they do not integrate into the host chromosome, transgene expression cannot be maintained indefinitely. To overcome these limitations, we have inserted an L1 retrotransposon/transgene element into a helper-dependent adenovirus to create a novel chimeric gene delivery vector. Efficient adenovirus-mediated delivery of the L1 element into cultured human cells results in subsequent retrotransposition and stable integration of the transgene. L1 retrotransposition frequency was found to correlate with increasing multiplicity of infection by the chimeric vector, and further retrotransposition from newly integrated elements was not observed on prolonged culture. Therefore, this vector, which utilizes components of low immunogenic potential, represents a novel two-stage gene delivery system capable of achieving high titers via the initial helper-dependent adenovirus stage and permanent transgene integration via the retrotransposition stage.

Original languageEnglish (US)
Pages (from-to)1417-1428
Number of pages12
JournalHuman Gene Therapy
Volume12
Issue number11
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Retroelements
Transgenes
Adenoviridae
Long Interspersed Nucleotide Elements
Gene Transfer Techniques
Genes
Cultured Cells
Chromosomes
Infection

ASJC Scopus subject areas

  • Genetics

Cite this

Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector. / Soifer, H.; Higo, C.; Kazazian, Jr H.; Moran, J. V.; Mitani, K.; Kasahara, Noriyuki.

In: Human Gene Therapy, Vol. 12, No. 11, 2001, p. 1417-1428.

Research output: Contribution to journalArticle

Soifer, H. ; Higo, C. ; Kazazian, Jr H. ; Moran, J. V. ; Mitani, K. ; Kasahara, Noriyuki. / Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector. In: Human Gene Therapy. 2001 ; Vol. 12, No. 11. pp. 1417-1428.
@article{7124ce0e739044e593582db85af388a0,
title = "Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector",
abstract = "Helper-dependent adenoviruses show great promise as gene delivery vectors. However, because they do not integrate into the host chromosome, transgene expression cannot be maintained indefinitely. To overcome these limitations, we have inserted an L1 retrotransposon/transgene element into a helper-dependent adenovirus to create a novel chimeric gene delivery vector. Efficient adenovirus-mediated delivery of the L1 element into cultured human cells results in subsequent retrotransposition and stable integration of the transgene. L1 retrotransposition frequency was found to correlate with increasing multiplicity of infection by the chimeric vector, and further retrotransposition from newly integrated elements was not observed on prolonged culture. Therefore, this vector, which utilizes components of low immunogenic potential, represents a novel two-stage gene delivery system capable of achieving high titers via the initial helper-dependent adenovirus stage and permanent transgene integration via the retrotransposition stage.",
author = "H. Soifer and C. Higo and Kazazian, {Jr H.} and Moran, {J. V.} and K. Mitani and Noriyuki Kasahara",
year = "2001",
doi = "10.1089/104303401750298571",
language = "English (US)",
volume = "12",
pages = "1417--1428",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector

AU - Soifer, H.

AU - Higo, C.

AU - Kazazian, Jr H.

AU - Moran, J. V.

AU - Mitani, K.

AU - Kasahara, Noriyuki

PY - 2001

Y1 - 2001

N2 - Helper-dependent adenoviruses show great promise as gene delivery vectors. However, because they do not integrate into the host chromosome, transgene expression cannot be maintained indefinitely. To overcome these limitations, we have inserted an L1 retrotransposon/transgene element into a helper-dependent adenovirus to create a novel chimeric gene delivery vector. Efficient adenovirus-mediated delivery of the L1 element into cultured human cells results in subsequent retrotransposition and stable integration of the transgene. L1 retrotransposition frequency was found to correlate with increasing multiplicity of infection by the chimeric vector, and further retrotransposition from newly integrated elements was not observed on prolonged culture. Therefore, this vector, which utilizes components of low immunogenic potential, represents a novel two-stage gene delivery system capable of achieving high titers via the initial helper-dependent adenovirus stage and permanent transgene integration via the retrotransposition stage.

AB - Helper-dependent adenoviruses show great promise as gene delivery vectors. However, because they do not integrate into the host chromosome, transgene expression cannot be maintained indefinitely. To overcome these limitations, we have inserted an L1 retrotransposon/transgene element into a helper-dependent adenovirus to create a novel chimeric gene delivery vector. Efficient adenovirus-mediated delivery of the L1 element into cultured human cells results in subsequent retrotransposition and stable integration of the transgene. L1 retrotransposition frequency was found to correlate with increasing multiplicity of infection by the chimeric vector, and further retrotransposition from newly integrated elements was not observed on prolonged culture. Therefore, this vector, which utilizes components of low immunogenic potential, represents a novel two-stage gene delivery system capable of achieving high titers via the initial helper-dependent adenovirus stage and permanent transgene integration via the retrotransposition stage.

UR - http://www.scopus.com/inward/record.url?scp=0034821174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034821174&partnerID=8YFLogxK

U2 - 10.1089/104303401750298571

DO - 10.1089/104303401750298571

M3 - Article

VL - 12

SP - 1417

EP - 1428

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 11

ER -